JamesAlanHellingerMD

Infectious Disease • Boston, MA

Assistant Professor, Medicine, Tufts Medical Center

Join to view full profile

Dr. Hellinger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Hellinger's full profile

Already have an account?

Office
750 Washington St
Nemc Box #836
Boston, MA 02111
Phone+1 617-636-5000
Is this information wrong?

Summary

Dr. James Hellinger is an infectious disease specialist in Boston, MA and is affiliated with Tufts Medical Center. He received his medical degree from University of California (San Francisco) School of Medicine and has been in practice 32 years.

Education & Training

Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1985 - 1986
University of California San Francisco School of MedicineClass of 1985

Certifications & Licensure

MA State Medical License 1987 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013

Publications & Presentations

PubMed

44 citations
Prevalence of Parental Misconceptions About Antibiotic Use.
Louise E. Vaz, Ken Kleinman, Matthew D. Lakoma, M. Maya Dutta-Linn, Chelsea Nahill, James Hellinger, Jonathan A. Finkelstein> ;Pediatrics. 2015 Aug 1
23 citations
Use of glomerular filtration rate estimating equations for drug dosing in HIV-positive patients.
Aghogho Okparavero, Hocine Tighiouart, Zipporah Krishnasami, Christina M. Wyatt, Hiba Graham, James Hellinger, Lesley A. Inker> ;Antiviral Therapy. 2013 Aug 1
68 citations
Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals.
Lesley A. Inker, Christina M. Wyatt, Rebecca Creamer, James Hellinger, Matthew Hotta, Maia Leppo, Andrew S. Levey, Aghogho Okparavero, Hiba Graham, Karen Savage, Chris...> ;Journal of Acquired Immune Deficiency Syndromes. 2012 Nov 1
49 citations
Antiviral Activity, Pharmacokinetics, and Safety of BMS-488043, a Novel Oral Small-Molecule HIV-1 Attachment Inhibitor, in HIV-1-Infected Subjects
George J. Hanna, Jacob Lalezari, James Hellinger, David A. Wohl, Richard E. Nettles, Anna Persson, Mark Krystal, Pin-Fang Lin, Richard J. Colonno, Dennis M. Grasela> ;Antimicrobial Agents and Chemotherapy. 2011 Feb 1
143 citations
HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance
Soo-Yon Rhee, Jonathan Taylor, W. Jeffrey Fessel, David Kaufman, William J. Towner, Paolo Troia, Peter Ruane, James Hellinger, Vivian Shirvani, Andrew R. Zolopa, Rober...> ;Antimicrobial Agents and Chemotherapy. 2010 Oct 1
5 citations
Relationship between plasma protease inhibitor concentrations and lipid elevations in HIV patients on a double-boosted protease inhibitor regimen (saquinavir/lopinavir...
Martin S. Rhee, James Hellinger, Sandy Sheble-Hall, Calvin J. Cohen, David J. Greenblatt> ;Journal of Clinical Pharmacology. 2010 Apr 1
30 citations
Correlates of HIV-1 viral suppression in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam:
Michael R. Jordan, H La, H D Nguyen, Heidi Sheehan, T T M Lien, D V Duong, James Hellinger, Christine Wanke, Alice M. Tang> ;International Journal of STD & AIDS. 2009 Jun 1
47 citations
HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use.
Geetanjali Chander, Seth Himelhoch, John A. Fleishman, James Hellinger, Paul Gaist, Richard D. Moore, Kelly A. Gebo> ;AIDS Care. 2009 May 14
72 citations
Health-Related Quality of Life in HIV-Infected Patients: The Role of Substance Use
P. Todd Korthuis, Laurie C. Zephyrin, John A. Fleishman, Somnath Saha, Joshua S. Josephs, Moriah Mc Sharry McGrath, James Hellinger, Kelly A. Gebo> ;AIDS Patient Care and Stds. 2008 Nov 1
13 citations
Impact of patient race on patient experiences of access and communication in HIV care.
P. Todd Korthuis, Somnath Saha, John A. Fleishman, Moriah Mc Sharry McGrath, Joshua S. Josephs, Richard D. Moore, Kelly A. Gebo, James Hellinger, Mary Catherine Beach> ;Journal of General Internal Medicine. 2008 Oct 2
30 citations
Substance abuse treatment in human immunodeficiency virus: The role of patient-provider discussions
Philip T. Korthuis, Joshua S. Josephs, John A. Fleishman, James Hellinger, Seth Himelhoch, Geetanjali Chander, Elizabeth B. Morse, Kelly A. Gebo> ;Journal of Substance Abuse Treatment. 2008 Oct 1
22 citations
Access to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug use
Seth Himelhoch, Geetanjali Chander, John A. Fleishman, James Hellinger, Paul Gaist, Kelly A. Gebo> ;General Hospital Psychiatry. 2007 Nov 1
62 citations
The impact of illicit drug use and substance abuse treatment on adherence to HAART.
Perrin L. Hicks, K.P. Mulvey, Geetanjali Chander, John A. Fleishman, Joshua S. Josephs, Philip T. Korthuis, James Hellinger, Paul Gaist, Kelly A. Gebo> ;AIDS Care. 2007 Oct 1
1 citations
HIV Blip Synching: Get the Timing Right
James Hellinger> ;Clinical Infectious Diseases. 2005 Nov 1
8 citations
Pilot study of saquinavir and lopinavir/ritonavir twice daily in protease inhibitor-naive HIV-positive patients.
James Hellinger, Calvin J. Cohen, Anne Morris, Sandy Sheble-Hall, Danielle Gordon, Clarissa Foy, Lenore Jackson-Pope, Abby Shevitz, Erno van Schaic> ;HIV Clinical Trials. 2005 Mar 1
227 citations
Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.
Kelly A. Gebo, John A. Fleishman, Richard Conviser, Erin D. Reilly, P. Todd Korthuis, Richard D. Moore, James Hellinger, Philip Keiser, Haya R. Rubin, Lawrence R. Cran...> ;Journal of Acquired Immune Deficiency Syndromes. 2005 Jan 1
23 citations
Patient Acceptance of Self-Injected Enfuvirtide at 8 and 24 Weeks
Calvin J. Cohen, James Hellinger, Margaret Johnson, Schlomo Staszewski, Neil Wintfeld, Kavita Patel, Jesse Green> ;HIV Clinical Trials. 2003 Sep 1
2 citations
Efficacy of nelfinavir in patients switched from ritonavir/saquinavir combination antiretroviral therapy.
James Hellinger, Calvin J. Cohen, Allan J. Stein, Joel E. Gallant, Joseph Gathe, Philip Keiser> ;HIV Clinical Trials. 2000 Sep 1
6 citations
Evaluation of simplified protease inhibitor dosing regimens for the treatment of HIV infection.
C. J. Cohen, James Hellinger, Norris D> ;The AIDS Reader. 2000 May 1
17 citations
A Randomized Study of the Safety and Antiretroviral Activity of Hydroxyurea Combined with Didanosine in Persons Infected with Human Immunodeficiency Virus Type 1
James Hellinger, Marika K. Iwane, Jeffery J. Smith, Alex N. Fleishman, Ramon A. Torres, Shannon Schrader, George Perez, Calvin J. Cohen, Gail Skowron, Michael F. Giord...> ;The Journal of Infectious Diseases. 2000 Feb 1
1 citations
Lack of Effect of Cimetidine on Lymphocyte Subsets in Patients Infected with Human Immunodeficiency Virus Type 1
C. J. Cohen, James Hellinger, J. Day, N. Salitsky, Abby Shevitz, Robert Zackin, Victor DeGruttola> ;Clinical Infectious Diseases. 1996 Nov 1
Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002.
Fleishman, J. A., Gebo, K. A., Reilly, E. D., Conviser, R., Christopher Mathews, W., Todd Korthuis, P., Hellinger, J., Rutstein, R., Keiser, P., Rubin, H., Moore, R. D.> ;Med Care. 2005 Sep
Join now to see all

Hospital Affiliations

Tufts Medical CenterBoston, Massachusetts

JamesAlanHellingerMD

Dr. Hellinger is on Doximity

Summary

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Publications & Presentations

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.